166 related articles for article (PubMed ID: 8378962)
1. Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
Sadoshima S; Fujii K; Ooboshi H; Ibayashi S; Fujishima M
Stroke; 1993 Oct; 24(10):1561-6; discussion 1566-7. PubMed ID: 8378962
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats.
Sadoshima S; Nagao T; Ibayashi S; Fujishima M
Hypertension; 1994 Jun; 23(6 Pt 1):781-5. PubMed ID: 8206577
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
Seymour AA; Swerdel JN; Abboa-Offei B
J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
[TBL] [Abstract][Full Text] [Related]
4. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
[TBL] [Abstract][Full Text] [Related]
5. Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Kishi K; Ikeda M
Gen Pharmacol; 1993 Jul; 24(4):863-6. PubMed ID: 8224740
[TBL] [Abstract][Full Text] [Related]
6. [The effect of captopril on cerebral blood flow in hypertensive rats before and after cerebral ischemia].
Adzhienko LM
Eksp Klin Farmakol; 1999; 62(5):18-20. PubMed ID: 10572745
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous glycerol on cerebral blood flow and tissue metabolism in acute cerebral ischemia in spontaneously hypertensive rats.
Fujishima M; Ishitsuka T; Yoshida F; Ibayashi S; Shiokawa O; Sadoshima S
Angiology; 1986 Feb; 37(2):92-8. PubMed ID: 3954158
[TBL] [Abstract][Full Text] [Related]
8. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
Ito T; Yamakawa H; Bregonzio C; Terrón JA; Falcón-Neri A; Saavedra JM
Stroke; 2002 Sep; 33(9):2297-303. PubMed ID: 12215602
[TBL] [Abstract][Full Text] [Related]
9. Calcium antagonist isradipine reduces metabolic alterations in acute cerebral ischemia in spontaneously hypertensive rats.
Ibayashi S; Nagao T; Kitazono T; Ooboshi H; Kitayama J; Sadoshima S; Fujishima M
Neurochem Res; 2000 Mar; 25(3):349-55. PubMed ID: 10761978
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischemic brain metabolism in hypertensive rats.
Sadoshima S; Ibayashi S; Fujii K; Nagao T; Sugimori H; Fujishima M
J Cereb Blood Flow Metab; 1995 Sep; 15(5):845-51. PubMed ID: 7673377
[TBL] [Abstract][Full Text] [Related]
11. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular aspects of converting-enzyme inhibition I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats.
Barry DI; Jarden JO; Paulson OB; Graham DI; Strandgaard S
J Hypertens; 1984 Dec; 2(6):589-97. PubMed ID: 6098608
[TBL] [Abstract][Full Text] [Related]
13. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
14. A new ergopeptide, CBM 36-733, improves ischaemic cerebral metabolism in spontaneously hypertensive rats.
Sadoshima S; Ibayashi S; Nakane H; Okada Y; Fujishima M
Drugs Exp Clin Res; 1991; 17(10-11):485-91. PubMed ID: 1841037
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ischemic and postischemic damage to brain metabolism and circulation by a novel Ca2+ channel antagonist, NC-1100, in spontaneously hypertensive rats.
Sadoshima S; Ibayashi S; Nakane H; Okada Y; Ooboshi H; Fujishima M
Eur J Pharmacol; 1992 Dec; 224(2-3):109-15. PubMed ID: 1468503
[TBL] [Abstract][Full Text] [Related]
16. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
17. Ceranapril and cerebral blood flow autoregulation.
Torup M; Waldemar G; Paulson OB
J Hypertens; 1993 Apr; 11(4):399-405. PubMed ID: 8390507
[TBL] [Abstract][Full Text] [Related]
18. Effects of clentiazem on cerebral ischemia induced by carotid artery occlusion in stroke-prone spontaneously hypertensive rats.
Kikkawa K; Yamauchi R; Suzuki T; Banno K; Murata S; Tetsuka T; Nagao T
Stroke; 1994 Feb; 25(2):474-80. PubMed ID: 8303759
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
20. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
